Performance evaluation of the new fully automated human immunodeficiency virus antigen‐antibody combination assay designed for blood screening

Abstract

The PRISM HIV antigen-antibody combination assay demonstrated a significant reduction of the window period for diagnosis of HIV infection. The assay demonstrated enhanced specificity and sensitivity along with broad subtype detection. The assay performance represents the "state-of-the art" technology for serologic blood screening of HIV infection.